Cargando…

Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells

A fundamental idea for targeting glioblastoma cells is to exploit the neurotropic properties of Zika virus (ZIKV) through its two outer envelope proteins, prM and E. This study aimed to develop envelope glycoproteins for pseudotyping retroviral vectors that can be used for efficient tumor cell infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grunwald, Vivien, Ngo, Hai Dang, Formanski, Jan Patrick, Jonas, Jana Sue, Pöhlking, Celine, Schwalbe, Birco, Schreiber, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572498/ https://www.ncbi.nlm.nih.gov/pubmed/37833934 http://dx.doi.org/10.3390/ijms241914487

Ejemplares similares

Isolation of Cells from Glioblastoma Multiforme Grade 4 Tumors for Infection with Zika Virus prME and ME Pseudotyped HIV-1
por: Pöhlking, Celine, et al.
Publicado: (2023)

Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy
por: Kretschmer, Maibritt, et al.
Publicado: (2020)

Improved Coinfection with Amphotropic Pseudotyped Retroviral Vectors
por: Wu, Yuehong, et al.
Publicado: (2009)

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation
por: Lee, Se Yeong, et al.
Publicado: (2022)

Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization
por: Schwalbe, Birco, et al.
Publicado: (2015)

Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping
por: Kim, Soo-hyun, et al.
Publicado: (2017)

The Use of Retroviral Pseudotypes for the Measurement of Antibody Responses to SARS Coronavirus
por: Temperton, Nigel James
Publicado: (2009)

Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors
por: Hwang, Bum-Yeol, et al.
Publicado: (2013)

Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope
por: Mirow, Manuela, et al.
Publicado: (2021)

Challenges on the development of a pseudotyping assay for Zika glycoproteins
por: Ruiz-Jiménez, Fernando, et al.
Publicado: (2021)

Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G)
por: Chen, Yong, et al.
Publicado: (2009)

The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albumins
por: Polzer, Svenja, et al.
Publicado: (2010)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
por: Duvergé, Alexis, et al.
Publicado: (2020)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
por: Tomás, Hélio A., et al.
Publicado: (2019)

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation
por: Toon, Kamilla, et al.
Publicado: (2021)

Enhanced protective efficacy of H5 subtype influenza vaccine with modification of the multibasic cleavage site of hemagglutinin in retroviral pseudotypes
por: Tao, Ling, et al.
Publicado: (2013)

Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors
por: Craig, Anthony T, et al.
Publicado: (2009)

Pseudotyped Lentiviral Vectors for Retrograde Gene Delivery into Target Brain Regions
por: Kobayashi, Kenta, et al.
Publicado: (2017)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
por: Deng, Longfei, et al.
Publicado: (2022)

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
por: Anson, Donald S
Publicado: (2004)

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors
por: Siegert, Sandra, et al.
Publicado: (2005)

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing
por: Radek, Constanze, et al.
Publicado: (2019)

Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors
por: Oakland, Mayumi, et al.
Publicado: (2013)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
por: Izumida, Mai, et al.
Publicado: (2020)

Enhanced gene expression from retroviral vectors
por: Blø, Magnus, et al.
Publicado: (2008)

Retroviral Vector Biosafety: Lessons from Sheep
por: Van den Broeke, Anne, et al.
Publicado: (2003)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
por: Dufait, Inès, et al.
Publicado: (2012)

Retroviral Vectors for Analysis of Viral Mutagenesis and Recombination
por: Rawson, Jonathan M.O., et al.
Publicado: (2014)

Postexit Surface Engineering of Retroviral/Lentiviral Vectors
por: Metzner, Christoph, et al.
Publicado: (2013)

Chikungunya Virus Glycoproteins Pseudotype with Lentiviral Vectors and Reveal a Broad Spectrum of Cellular Tropism
por: Hu, Dakang, et al.
Publicado: (2014)

Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2016)

Retroviral Gene Vectors Show Clear Target Preferences
Publicado: (2004)

Retroviral Vectors: Post Entry Events and Genomic Alterations
por: Nowrouzi, Ali, et al.
Publicado: (2011)

Dual-vector prodrug activator gene therapy using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)

Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors
por: Matsumoto, Hiroshi, et al.
Publicado: (2010)

Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
por: Deng, Yao, et al.
Publicado: (2013)

Highly Efficient Retrograde Gene Transfer into Motor Neurons by a Lentiviral Vector Pseudotyped with Fusion Glycoprotein
por: Hirano, Miyabi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bu9ro9cj38ee98n4bc4m9sq005